Google
COR Stock Analysis — CENCORA INC. (Healthcare >> Medical Distribution)
COR FAQ
What is COR's P/E ratio?
CENCORA INC. (COR) currently trades at a P/E ratio of 21.03.
What is COR's ROE?
CENCORA INC. reports a Return on Equity (ROE) of 75.01%.
What is COR's dividend yield?
CENCORA INC. offers a dividend yield of 0.72%.
What is COR's Quality Score?
Our AI rates COR's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy COR?
Our AI Timing Score for COR is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does COR belong to?
CENCORA INC. is classified under the Healthcare >> Medical Distribution sector on the NYSE exchange
COR AI Analysis Summary
Our AI summary for COR: CENCORA INC. (NYSE), Healthcare >> Medical Distribution sector. The stock currently trades at a P/E of 21.03, ROE of 75.01%, a dividend yield of 0.72%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 311.34
Price
-0.89
(-0.29%)
Day Change
|
|
|---|
COR, the overall quality is not good ( Quality = 31) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is not quite good , ...
| Quality Factors |
|
50% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
2339
|
| Magic Formula Rank by ROE |
2339
|
| Magic Formula Rank by ROIC |
1696
|
| Price | 311.34 |
| PBV / Sector |
16.95 / -7.19
|
| Earning Per Share | 13.06 |
| PE / Sector |
21.03 / 20.35
|
| PEG or PE/Growth / Sector |
1,051.59 / 211.57
|
| Average 1M Daily Value |
327.33 M
GREAT
|
| Average 1W Daily Value |
287.06 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
12% |
| Registration Details |
| Analyze Date | 2026-08-01 07:59:40 |
| Symbol | COR |
| Name | CENCORA INC. |
| Sector | Healthcare >> Medical Distribution |
| Market | NYSE |
| Listed Shares | 194.56 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 60,747.80 / 45,764.92 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1 West First Avenue, Conshohocken, PA, United States, 19428-1800
Phone: 610 727 7000
Website: https://www.cencora.com
Employees: 47,000
Description: Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Distribution
Click a bubble to view stock details · Bubble size represents market capitalization share
